Phio Pharmaceuticals Corp.
PHIO· Nasdaq
Released Apr 1, 2024, after the close
10-K filed Apr 1, 2024, 92 days after period end · 0001683168-24-002021
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | — | $0.00 |
| Net Income | -$1.90M | -$2.73M | -$3.45M |
Phio Pharmaceuticals Corp. · CIK 1533040 · Engraved from SEC EDGAR
| -$2.46M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.